Priya Misra

Single, very low rituximab doses in healthy volunteers - a pilot and a randomized trial: implications for dosing and biosimilarity testing

Christian Schoergenhofer, Michael Schwameis, Christa Firbas et al. · Scientific Reports · 2018 · 45 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +13

Confirmation of Biosimilarity in a Pharmacokinetic/Pharmacodynamic Study in Healthy Volunteers for an Analytically Highly Similar Pegfilgrastim

Kalpna Desai, Tina Catalano, Gurinder Rai et al. · Clinical Pharmacology in Drug Development · 2016 · 24 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +13

Clinical confirmation to demonstrate similarity for a biosimilar pegfilgrastim: a 3-way randomized equivalence study for a proposed biosimilar pegfilgrastim versus US-licensed and EU-approved reference products in breast cancer patients receiving myelosuppressive chemotherapy

Kalpna Desai, Priya Misra, Sanyukta Kher et al. · Experimental Hematology and Oncology · 2018 · 13 citations · Full text

Medicine, Oncology, Pharmacology +15